Tese Nanoparticle-Integrated Exosomes for Accelerated Diabetic Pressure Ulcer Healing via NIR-II Triggered Synergy
April 2026
in “
Biomaterials and Biosystems
”
New to Exosomes? There is a guide in the encyclopedia. Read the guide → Studysummary This study found that combining multiple low-dose exosome injections with NIR-II-responsive selenium telluride-mediated photothermal therapy significantly improved healing in diabetic mice with pressure ulcers, enhancing wound closure, hair follicle regeneration, and collagen remodeling compared to single high-dose exosome treatment.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
This study explores a novel therapeutic approach for diabetic pressure ulcers by combining human adipose-derived mesenchymal stem cell-derived exosomes (hADSC-Exos) with selenium telluride (TeSe) nanoparticle-mediated photothermal therapy (PTT) triggered by near-infrared-II (NIR-II) irradiation. The research, conducted on a diabetic mouse model, demonstrates that multiple low-dose exosome injections are more effective than a single high-dose in promoting wound healing. The combination therapy significantly enhances wound closure, hair follicle regeneration, and collagen remodeling within 21 days. TeSe nanoparticles exhibit effective NIR-II photothermal conversion and antibacterial properties, which, when integrated with exosomes, boost fibroblast migration and proliferation. Histological analysis shows increased angiogenesis, reduced inflammation, and improved collagen remodeling, suggesting this synergistic therapy as a promising treatment for diabetic pressure ulcers.
